MTTP and atherosclerosis: Notebly, implitapide (a molecule containing α-carboline moiety, 6) has reached clinical trails as an microsomal triglyceride transfer protein (MTP) inhibitor to reduce the progression of atherosclerosis (Ueshima et al., 2005) (Figure 1).